Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients

Haematologica. 2003 Aug;88(8):958-60.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / therapeutic use
  • Bone Marrow / drug effects*
  • Bone Marrow / metabolism
  • Bone Marrow / pathology*
  • Drug Administration Schedule
  • Humans
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology*
  • Thalidomide / administration & dosage
  • Thalidomide / therapeutic use*

Substances

  • Angiogenesis Inhibitors
  • Thalidomide